Urticaria after breakthrough Omicron BA.5.1 severe acute respiratory syndrome coronavirus 2 infection in a triple-vaccinated (Pfizer) patient: a case report

• Published in: Journal of medical case reports Vol. 17; no. 1; pp. 177 - 6
• Main Authors: Ciuoderis, Karl, Perez, Laura, Alvarez, Catalina, Usuga, Jaime, Carvajal, Leidi, Cardona, Andrés, Maya, Maria A., Cloherty, Gavin, Hernandez-Ortiz, Juan P., Osorio, Jorge E.
• Format: Journal Article
• Language: English
• Published: England BioMed Central Ltd 04.05.2023; BioMed Central; BMC
• Subjects: Adult; Amino acids; Analysis; Antibodies, Viral; Biological response modifiers; Case Report; Case reports; Chemokines; Coronaviruses; COVID-19; COVID-19 vaccines; Cytokines; Development and progression; Disease; DNA sequencing; Genomes; Genomics; Health aspects; Hispanic Americans; Humans; Immunoglobulins; Infections; Interferon; Interferon gamma; Interleukins; Male; Medical research; Medicine, Experimental; Mutation; Nucleotide sequencing; Pathogenesis; Pharmaceutical industry; Postvaccination; Proteins; Rash; SARS-CoV-2; Serology; Severe acute respiratory syndrome; Severe acute respiratory syndrome coronavirus 2; Skin; Steroids; Tumor necrosis factor-TNF; Urticaria; Urticaria - etiology; Vaccination; Viral infections; Whole genome sequencing; Colombia; United States; United States > US; Case report; Rash; SARS-CoV-2; Skin; Postvaccination; Urticaria

Severe acute respiratory syndrome coronavirus 2 continues to threaten public health. The virus is causing breakthrough infections in vaccinated individuals. Also, scarce information is available about cutaneous manifestations after severe acute respiratory syndrome coronavirus 2 infection. A case of...